Shahzad Malik
CIK 1380178 · last filed 2021-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.24M
Companies
8
Total Filings
30
Lifetime Open-Market Net
-$12.43M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Acutus Medical, Inc. (AFIB) Delisted | Director | 69,458 | $0.09 | $6.3K | $0 | 3 | 2021-06-22 |
| Iterum Therapeutics plc (ITRM) Delisted | Director | 838,325 | $0.03 | $25.1K | $3.08M | 4 | 2020-01-23 |
| Aravive, Inc. (ARAV) Delisted | Director | — | $0.04 | — | $0 | 3 | 2019-09-13 |
| Axonics, Inc. (AXNX) Delisted | Director | 60,734 | $70.98 | $4.31M | $0 | 2 | 2018-12-10 |
| Aravive, Inc. (VSAR) Delisted | Director | 1,645,438 | — | — | -$9.73M | 9 | 2017-12-22 |
| Histogen Inc. (CNAT) Delisted | Director | 1,888,091 | — | — | $2.08M | 3 | 2016-06-27 |
| AGEN | Director | 1,587,302 | $3.30 | $5.24M | -$7.87M | 5 | 2016-06-17 |
| EBS | Director | — | $8.32 | — | $0 | 1 | 2007-06-18 |
Recent Filings · Page 2 of 3
30 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-05-30 | Iterum Therapeutics plc (ITRM) Delisted | Mixed | +868,161 | $3.08M | EDGAR |
| 2018-05-29 | Iterum Therapeutics plc (ITRM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-12-22 | Aravive, Inc. (VSAR) Delisted | Grant (A) | +11,200 | $0 | EDGAR |
| 2017-06-06 | Aravive, Inc. (VSAR) Delisted | Grant (A) | +3,480 | $0 | EDGAR |
| 2017-03-17 | Aravive, Inc. (VSAR) Delisted | Sell (S) | −483,670 | -$8.76M | EDGAR |
| 2017-03-15 | Aravive, Inc. (VSAR) Delisted | Sell (S) | −166,330 | -$3.18M | EDGAR |
| 2016-06-27 | Histogen Inc. (CNAT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-17 | AGEN | Grant (A) | — | $0 | EDGAR |
| 2016-05-20 | Aravive, Inc. (VSAR) Delisted | Grant (A) | +4,625 | $0 | EDGAR |
| 2015-07-01 | Aravive, Inc. (VSAR) Delisted | Grant (A) | +4,575 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.